{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:27:48Z","timestamp":1790015268308,"version":"4.0.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,7]]},"DOI":"10.7759\/cureus.83697","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T06:34:26Z","timestamp":1746686066000},"source":"Crossref","is-referenced-by-count":2,"title":["Case Series on Varied Presentations of Amlodipine Toxicity"],"prefix":"10.7759","author":[{"given":"S","family":"Sridhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhiya","family":"Narendiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugan","family":"K R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahasyaa","family":"Adalarasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Shivamalarvizhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199550030-00009","article-title":"Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease","volume":"50","author":"Haria M","year":"1995","unstructured":"Haria M, Wagstaff AJ. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs. 1995, 50:560-586. 10.2165\/00003495-199550030-00009","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.01.016","article-title":"Calcium channel antagonists: clinical uses--past, present and future","volume":"74","author":"Triggle DJ","year":"2007","unstructured":"Triggle DJ. Calcium channel antagonists: clinical uses--past, present and future. Biochem Pharmacol. 2007, 74:1-9. 10.1016\/j.bcp.2007.01.016","journal-title":"Biochem Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.11.3_pt_2.ii42","article-title":"Side effects of calcium channel blockers","volume":"11","author":"Russell RP","year":"1988","unstructured":"Russell RP. Side effects of calcium channel blockers. Hypertension. 1988, 11:II42-4. 10.1161\/01.hyp.11.3_pt_2.ii42","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/sja.sja_388_21","article-title":"Amlodipine overdose complicated by non-cardiogenic pulmonary edema and diffuse alveolar hemorrhage: a case report","volume":"16","author":"Bringgold WR","year":"2022","unstructured":"Bringgold WR, Long MT. Amlodipine overdose complicated by non-cardiogenic pulmonary edema and diffuse alveolar hemorrhage: a case report. Saudi J Anaesth. 2022, 16:104-107. 10.4103\/sja.sja_388_21","journal-title":"Saudi J Anaesth"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.965827","article-title":"Treatment for calcium channel blocker poisoning: a systematic review","volume":"52","author":"St-Onge M","year":"2014","unstructured":"St-Onge M, Dub\u00e9 PA, Gosselin S, et al.. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila). 2014, 52:926-944. 10.3109\/15563650.2014.965827","journal-title":"Clin Toxicol (Phila)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.07.2011.4467","article-title":"Amlodipine poisioning complicated with acute non-cardiogenic pulmonary oedema","volume":"2011","author":"Hasson R","year":"2011","unstructured":"Hasson R, Mulcahy V, Tahir H. Amlodipine poisioning complicated with acute non-cardiogenic pulmonary oedema. BMJ Case Rep. 2011, 2011:bcr0720114467. 10.1136\/bcr.07.2011.4467","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0972-5229.123452","article-title":"Shock due to amlodipine overdose","volume":"17","author":"Upreti V","year":"2013","unstructured":"Upreti V, Ratheesh VR, Dhull P, Handa A. Shock due to amlodipine overdose. Indian J Crit Care Med. 2013, 17:375-377. 10.4103\/0972-5229.123452","journal-title":"Indian J Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr052","article-title":"Acute severe intestinal obstruction secondary to amlodipine toxicity","volume":"105","author":"Devasahayam J","year":"2012","unstructured":"Devasahayam J, Pillai U, Uppaluri C. Acute severe intestinal obstruction secondary to amlodipine toxicity. QJM. 2012, 105:467-469. 10.1093\/qjmed\/hcr052","journal-title":"QJM"},{"key":"ref9","article-title":"Managing Calcium Channel Blocker Toxicity: Strategies for Optimal Patient Outcomes","author":"Karunarathna I","unstructured":"Karunarathna I, Priyalath N, Withanagama C, Jayawardana A. Managing Calcium Channel Blocker Toxicity: Strategies for Optimal Patient Outcomes."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S374887","article-title":"Calcium channel blocker toxicity: a practical approach","volume":"15","author":"Alshaya OA","year":"2022","unstructured":"Alshaya OA, Alhamed A, Althewaibi S, et al.. Calcium channel blocker toxicity: a practical approach. J Multidiscip Healthc. 2022, 15:1851-1862. 10.2147\/JMDH.S374887","journal-title":"J Multidiscip Healthc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14740\/cr646w","article-title":"Critical management of severe hypotension caused by amlodipine toxicity managed with hyperinsulinemia\/euglycemia therapy supplemented with calcium gluconate, intravenous glucagon and other vasopressor support: review of literature","volume":"9","author":"Kumar K","year":"2018","unstructured":"Kumar K, Biyyam M, Bajantri B, Nayudu S. Critical management of severe hypotension caused by amlodipine toxicity managed with hyperinsulinemia\/euglycemia therapy supplemented with calcium gluconate, intravenous glucagon and other vasopressor support: review of literature. Cardiol Res. 2018, 9:46-49. 10.14740\/cr646w","journal-title":"Cardiol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346442-case-series-on-varied-presentations-of-amlodipine-toxicity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T06:34:27Z","timestamp":1746686067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346442-case-series-on-varied-presentations-of-amlodipine-toxicity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.83697","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}